GoPro, Inc. (NASDAQ:GPRO) shares moved down -4.75% in last trading session and ended the day at $32.31. GPRO Gross Margin is 46.30% and its has a return on assets of 19.50%. GoPro, Inc. (NASDAQ:GPRO) quarterly performance is -40.31%.
GoPro, Inc. produces mountable and wearable cameras and accessories, which the Company refers to as capture devices. Additionally, the Company develops and provides desktop editing software and mobile applications for free to consumers.
GoPro, Inc. (NASDAQ:GPRO) said that, it will launch additional 360-degree content on Facebook where users can expect a variety of never-before-seen, immersive experiences from the vantage point of GoPro world-class athletes, top chefs and more.
Lululemon Athletica Inc. (NASDAQ:LULU) ended the last trading day at $52.58. Company weekly volatility is calculated as 3.89% and price to cash ratio as 13.65. Lululemon Athletica Inc. (NASDAQ:LULU) showed a weekly performance of -0.62%.
lululemon athletica inc. is a designer and retailer of technical athletic apparel. The Company offers a line of apparel and accessories for women, men and female youth. Its apparel assortment includes items, such as pants, shorts, tops and jackets designed for healthy lifestyle activities and athletic pursuits, such as yoga, running, general fitness and dance-inspired apparel for female youth.
Lululemon Athletica Inc. (NASDAQ:LULU) reported that net revenue in 2Q2015 jumped 16% to $453 million from $390.7 million in the same period, a year earlier. The total comparable sales surged 11% in 2Q on a constant dollar basis. It covered direct sales as well as comparable store sales to consumer.
On 25 September, Mast Therapeutics, Inc. (NYSEMKT:MSTX) shares moved down -0.92% and was closed at $0.45. MSTX EPS growth in last 5 year was 41.90%. Mast Therapeutics, Inc. (NYSEMKT:MSTX) year to date (YTD) performance is -19.62%.
Mast Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company develops therapies for serious or life-threatening diseases with unmet needs. The Company leverages its Molecular Adhesion and Sealant Technology (MAST) platform, to develop MST-188 (vepoloxamer) Injection, the Company’s lead product candidate. Vepoloxamer is being tested in a Phase III clinical study called EPIC for the treatment of vaso-occlusive crisis in patients with sickle cell disease. The Company also develops AIR001, a sodium nitrite solution for intermittent inhalation through nebulizer.
Mast Therapeutics, Inc. (NYSEMKT:MSTX) announced that it will host its first Analyst & Investor Day on October 7, 2015 at the Palace Hotel in New York City. Mast Therapeutics’ full executive management team will provide an update on its vepoloxamer and AIR001 programs.
Corium International, Inc. (NASDAQ:CORI) shares moved down -15.87% in last trading session and ended the day at $8.80. CORI Gross Margin is 17.60% and its has a return on assets of -40.80%. Corium International, Inc. (NASDAQ:CORI) quarterly performance is -35.67%.
Corium International, Inc. is a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty pharmaceutical products that leverage its broad experience in transdermal and transmucosal delivery systems. The Company’s marketed products are Clonidine Transdermal Delivery System, or TDS, Fentanyl TDS and four Crest Advanced Seal Whitestrips products.
Corium International, Inc. (NASDAQ:CORI) was upgraded by Zacks from a “hold” rating to a “buy” rating in a report issued on Wednesday, Analyst Ratings Net reports. The firm presently has a $12.00 price objective on the biopharmaceutical company’s stock. Zacks‘s price objective indicates a potential upside of 8.60% from the company’s previous close.
Arch Coal Inc. (NYSE:ACI) caters to the Basic Materials space. It has a net profit margin of -22.00% and weekly performance is -13.51%. On the last day of trading company shares ended up at $3.01. Arch Coal Inc. (NYSE:ACI) distance from 50-day simple moving average (SMA50) is -9.39%.
Arch Coal, Inc. is a coal producer, which sells all of its coal to power plants, steel mills and industrial facilities. The Company is engaged in the production of thermal and metallurgical coal from surface and underground mines located throughout the United States, for sale to utility, industrial and steel producers both in the United States and around the world.
On 24 September, Arch Coal Inc. (NYSE:ACI) announced the extension of its (i) pending private offer to exchange (the “2020 Exchange Offer”) new 6.25% Trust Certificates due 2021 and a cash payment for any and all of its outstanding 7.25% Senior Notes due 2020 and (ii) pending concurrent private offer to exchange Trust Certificates, 8.00% Senior Secured Notes due 2022 and 12.00% Senior Secured Second Lien Notes due 2023 (the “New 2023 Secured Notes”) for its outstanding 7.000% Senior Notes due 2019 (“Old 7.000% 2019 Notes”), 9.875% Senior Notes due 2019 and 7.250% Senior Notes due 2021.
Leave a Reply